Back to Search
Start Over
Rituximab monotherapy in splenic marginal zone lymphoma: prolonged responses and potential benefit from maintenance.
- Source :
-
Blood [Blood] 2018 Aug 09; Vol. 132 (6), pp. 666-670. Date of Electronic Publication: 2018 Jun 18. - Publication Year :
- 2018
- Subjects :
- Adult
Aged
Aged, 80 and over
Drug Administration Schedule
Drug Evaluation
Female
Follow-Up Studies
Humans
Kaplan-Meier Estimate
Maintenance Chemotherapy
Male
Middle Aged
Progression-Free Survival
Remission Induction
Retrospective Studies
Treatment Outcome
Antineoplastic Agents, Immunological therapeutic use
Lymphoma, B-Cell, Marginal Zone drug therapy
Rituximab therapeutic use
Splenic Neoplasms drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1528-0020
- Volume :
- 132
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Blood
- Publication Type :
- Editorial & Opinion
- Accession number :
- 29914978
- Full Text :
- https://doi.org/10.1182/blood-2018-02-833608